FibroBiologics, Inc. has closed a private placement offering, securing $3 million in gross proceeds. The offering involved the sale of common stock (or pre-funded warrants in lieu thereof) and two series of warrants. The company also has the potential to raise an additional $6 million if all warrants are exercised for cash. The net proceeds will be used for working capital and general corporate purposes. The securities were sold under an exemption from registration, and a resale registration statement will be filed. Stockholder approval is required for the exercise of the warrants.